Your browser doesn't support javascript.
loading
Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry.
Maffeis, Claudio; Birkebaek, Niels H; Konstantinova, Maia; Schwandt, Anke; Vazeou, Andriani; Casteels, Kristina; Jali, Sujata; Limbert, Catarina; Pundziute-Lycka, Auste; Toth-Heyn, Peter; de Beaufort, Carine; Sumnik, Zdenek; Cherubini, Valentino; Svensson, Jannet; Pacaud, Daniele; Kanaka-Gantenbein, Christina; Shalitin, Shlomit; Bratina, Natasa; Hanas, Ragnar; Alonso, Guy T; Poran, Luxmi; Pereira, Ana L; Marigliano, Marco.
Afiliación
  • Maffeis C; Pediatric Diabetes and Metabolic Disorders Unit, University of Verona, University City Hospital, Verona, Italy.
  • Birkebaek NH; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
  • Konstantinova M; Clinic for Endocrinology, Diabetes and Genetics, Medical University Sofia, University Pediatric Hospital, Sofia, Bulgaria.
  • Schwandt A; Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
  • Vazeou A; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
  • Casteels K; Diabetes Center, P & A Kyriakou Children's Hospital, Athens, Greece.
  • Jali S; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Limbert C; Department of Development and Regeneration, University of Leuven, Leuven, Belgium.
  • Pundziute-Lycka A; KLE Diabetes Centre, KLE University JNMC and KLE'S Dr. Prabhakar Kore Hospital & MRC, Belagavi, India.
  • Toth-Heyn P; Hospital Dona Estefânia, Unit of Pediatric Endocrinology and Diabetes, Lisbon, Portugal.
  • de Beaufort C; Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Sumnik Z; Ist. Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Cherubini V; Deccp, Pediatric Clinic/Centre Hospitalier de Luxembourg, Luxembourg, Grand Duche de Luxembourg.
  • Svensson J; Department of Pediatrics, Motol University Hospital, Prague, Czech Republic.
  • Pacaud D; Department of Women's and Children Health, Salesi Hospital, Ancona, Italy.
  • Kanaka-Gantenbein C; Department of Pediatric and adolescents, Copenhagen University hospital, Herlev, Denmark.
  • Shalitin S; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
  • Bratina N; Diabetes Center, First Department of Pediatrics, Medical School,National and Kapodistrian University of Athens, Agia Sophia Children's Hospital, Athens, Greece.
  • Hanas R; The Jesse Z. and Lea Shafer Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Alonso GT; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Poran L; University Children's Hospital, Department of Endocrinology, Diabetes and Metabolic Diseases, Ljubljana, Slovenia.
  • Pereira AL; The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden and NU Hospital Group, Uddevalla, Sweden.
  • Marigliano M; Barbara Davis Center, University of Colorado, Aurora, Colorado.
Pediatr Diabetes ; 19(7): 1211-1220, 2018 11.
Article en En | MEDLINE | ID: mdl-30033651
OBJECTIVE: To assess the prevalence of underweight (UW), overweight (OW), and obesity in children and adolescents with type 1 diabetes (T1D). METHODS: An international cross-sectional study including 23 026 T1D children (2-18 years, duration of diabetes ≥1 year) participating in the SWEET prospective, multicenter diabetes registry. Body mass index SD score (BMI-SDS) was calculated using the World Health Organization BMI charts. Children were categorized as UW (BMI-SDS < -2SD), OW (+1SD < BMI-SDS ≤ +2SD), and obese (OB) (BMI-SDS > +2SD). Hierarchic regression models were applied with adjustment for sex, age, and duration of diabetes. RESULTS: The prevalence of UW, OW, and obesity was: 1.4%, 22.3%, and 7.3% in males and 0.6%, 27.2%, and 6.8% in females. Adjusted BMI-SDS was significantly higher in females than in males (mean ± SEM: 0.54 ± 0.05 vs 0.40 ± 0.05, P < 0.0001). In males, BMI-SDS significantly decreased by age (P < 0.0001) in the first three age categories 0.61 ± 0.06 (2 to <10 years), 0.47 ± 0.06 (10 to <13 years), 0.34 ± 0.05 (13 to <16 years). In females, BMI-SDS showed a U-shaped distribution by age (P < 0.0001): 0.54 ± 0.04 (2 to <10 years), 0.39 ± 0.04 (10 to <13 years), 0.55 ± 0.04 (13 to <16 years). BMI-SDS increased by diabetes duration (<2 years: 0.38 ± 0.05, 2 to <5 years: 0.44 ± 0.05, and ≥5 years: 0.50 ± 0.05, P < 0.0001). Treatment modality did not affect BMI-SDS. Adjusted HbA1c was significantly higher in females than in males (8.20% ± 0.10% vs 8.06% ± 0.10%, P < 0.0001). In both genders, the association between HbA1c and BMI-SDS was U-shaped with the highest HbA1c in the UW and obesity groups. CONCLUSIONS: The high rate of OW and obesity (31.8%) emphasize the need for developing further strategies to prevent and treat excess fat accumulation in T1D.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Diabetes Mellitus Tipo 1 / Obesidad Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Diabetes Mellitus Tipo 1 / Obesidad Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Diabetes Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia